Search results
BioMarin's (BMRN) Q2 Earnings Top, Voxzogo Drives Sales
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported second-quarter 2022 adjusted earnings of 59 cents per share,...
BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported adjusted earnings of 45 cents per share in third-quarter 2022,...
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
Barrons.com· 2 months agoBARRON'S COVER - MAIN Understanding the products from pharmaceutical companies could be the most...
5 Stocks Likely to Gain on Q4 Earnings Today After Market Close
Zacks via Yahoo Finance· 4 months agoWe have narrowed our search to five large-cap stocks that are poised to beat on earnings today after...
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
Zacks via Yahoo Finance· 4 months agoBioMarin Pharmaceutical BMRN reported fourth-quarter 2023 adjusted earnings per share of 49 cents,...
BioMarin (BMRN) Q4 Earnings Miss, Sales Beat, Stock Down
Zacks via Yahoo Finance· 1 year agoBioMarin (BMRN) reports mixed Q4 results as it misses estimates for earnings but beats the same for...
TG Therapeutics (TGTX) Gets FDA Nod for Multiple Sclerosis Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves TG Therapeutics' (TGTX) Briumvi (ublituximab-xiiy) for treating relapsing forms of...
BioMarin (BMRN) Q3 Earnings in Line, Sales Miss, '23 View Cut
Zacks via Yahoo Finance· 7 months agoBioMarin's (BMRN) Q3 earnings are in line with estimates but miss the mark on sales. The company...
Schneider in Deal Talks With US Software Maker Bentley
Bloomberg via Yahoo Finance· 2 months ago(Bloomberg) -- Schneider Electric SE is in talks about a potential deal with engineering software...
Catalent reaches settlement with Elliott to explore strategic review
Reuters via Yahoo Finance· 10 months ago(Reuters) -Contract drug maker Catalent Inc said on Tuesday it had added four new directors to its...